Bio Green Med SolutionBGMS

13F holders, Q3 2025 (September 30)
6holders +5
6new positions
0sold out
$4.94avg. 13F price*

At the end of Q3 2025, 6 institutions reported holding Bio Green Med Solution Inc. (BGMS) in their 13F filings, up 5 from Q2 2025. 6 opened new positions and 0 sold out. The largest holders were Tower Research Capital LLC (TRC) ($5K), UBS Group AG ($198) and SBI Securities Co., Ltd. ($15).

Company
Bio Green Med Solution Inc.
CUSIP
23254L876
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q2 2025: 1Q2 2025Q3 2025: 6Q3 2025Q4 2025: 9Q4 2025Q1 2026: 9Q1 2026Q2 2026: 7Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions6$6K
Exits0$0

All 13F filers, Q2 2025 → Q3 2025: 1,114 shares bought and 72 shares sold, net +1,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

Tower Research Capital LLC (TRC) 0.00% New 1,070 $5K
UBS Group AG 0.00% New 40 $198
SBI Securities Co., Ltd. 0.00% Reduce -96.0% 3 $15
Bank of America Corp. 0.00% New 2 $10
Osaic Holdings, Inc. 0.00% New 1 $8
Archer Investment Corp 0.00% New 1 $5

"% of holder's portfolio" is BGMS's weight in each manager's 13F, not the share of Bio Green Med Solution Inc. the manager owns.